Table 1. Correlation of clinicopathological parameters and MVD or VASH1 expression in the 167 study patients.
| Characteristic | No. of patients (%) | MVD (mean±s.d.) | P-value | VASH1 density (mean±s.d.) | P-value |
|---|---|---|---|---|---|
|
Age (years) | |||||
| <65 | 99 (59.3) | 133.1±58.3 | 0.201 | 9.3±7.4 | 0.101 |
| ≧65 |
68 (40.7) |
115.6±41.2 |
|
10.8±7.2 |
|
|
PSA | |||||
| <15 | 138 (82.6) | 120.5±47.5 | 0.588 | 9.4±6.8 | 0.139 |
| ≧15 |
29 (17.4) |
133.7±67.9 |
|
12.3±8.9 |
|
|
Gleason score | |||||
| ≦6 | 69 (41.3) | 105.8±42.2 | <0.001 | 7.5±5.6 | <0.001 |
| ≧7 |
98 (58.7) |
134.6±54.4 |
|
11.6±7.9 |
|
|
Pathological Tstage | |||||
| ≦pT2 | 113 (67.7) | 111.2±46.3 | <0.001 | 8.6±6.5 | <0.001 |
| ≧pT3 | 54 (32.3) | 146.8±54.3 | 12.6±8.2 | ||
Abbreviations: MVD=microvessel density; PSA=prostate-specific antigen; VASH1=vasohibin-1.